RABCID

This brand name is authorized in Nigeria.

Active ingredients

The drug RABCID contains one active pharmaceutical ingredient (API):

1	Rabeprazole UNII 3L36P16U4R - RABEPRAZOLE SODIUM
	Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump).
	Read more about Rabeprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-100682	Capsule	RABCID CAPSULES CAP 20 mg 3x10 Capsules	15 NF-PP-313652 RABCID CAPSULES RABEPRAZOLE SODIUM RABEPRAZOLE SODIUM ENTERIC COATED PELLET 8.5% w/w (EQUIVALENT TO RABEPRAZOLE SODIUM 20MG) 470.58G A11-100682 Drugs Nigerian Products 3x10capsules POM 1 2/9/2023 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC04	Rabeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-100682